- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1912
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Repurposing mesalazine against cardiac fibrosis in vitro ; day:16 ; month:10 ; year:2020 ; pages:1-11
Naunyn-Schmiedeberg's archives of pharmacology ; (16.10.2020), 1-11
- Creator
-
Hoffmann, Maximilian
Kant, Theresa A.
Emig, Ramona
Rausch, Johanna S. E.
Newe, Manja
Schubert, Mario
Künzel, Karolina
Winter, Luise
Klapproth, Erik
Peyronnet, Remi
Ravens, Ursula
El-Armouche, Ali
Künzel, Stephan R.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00210-020-01998-9
- URN
-
urn:nbn:de:101:1-2020113018335476083527
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hoffmann, Maximilian
- Kant, Theresa A.
- Emig, Ramona
- Rausch, Johanna S. E.
- Newe, Manja
- Schubert, Mario
- Künzel, Karolina
- Winter, Luise
- Klapproth, Erik
- Peyronnet, Remi
- Ravens, Ursula
- El-Armouche, Ali
- Künzel, Stephan R.
- SpringerLink (Online service)
Other Objects (12)
Repurposing mesalazine against cardiac fibrosis in vitro
Repurposing of anticancer drugs: in vitro and in vivo activities against Schistosoma mansoni
Radotinib attenuates TGFβ -mediated pulmonary fibrosis in vitro and in vivo: exploring the potential of drug repurposing
Drug repurposing against COVID-19: focus on anticancer agents
Repurposing mebendazole against triple-negative breast cancer CNS metastasis
Repurposing anti-mesothelin CAR-NK immunotherapy against colorectal cancer
Repurposing of approved antivirals against dengue virus serotypes: an in silico and in vitro mechanistic study
A drug repurposing study identifies novel FOXM1 inhibitors with in vitro activity against breast cancer cells
Nifuroxazide ameliorates pulmonary fibrosis by blocking myofibroblast genesis: a drug repurposing study
Drug repurposing
Data-driven host-directed antiviral drug repurposing against emerging pathogens
Robust antiviral activity of commonly prescribed antidepressants against emerging coronaviruses: in vitro and in silico drug repurposing studies
Repurposing mesalazine against cardiac fibrosis in vitro
Repurposing of anticancer drugs: in vitro and in vivo activities against Schistosoma mansoni
Radotinib attenuates TGFβ -mediated pulmonary fibrosis in vitro and in vivo: exploring the potential of drug repurposing
Drug repurposing against COVID-19: focus on anticancer agents
Repurposing mebendazole against triple-negative breast cancer CNS metastasis
Repurposing anti-mesothelin CAR-NK immunotherapy against colorectal cancer
Repurposing of approved antivirals against dengue virus serotypes: an in silico and in vitro mechanistic study
A drug repurposing study identifies novel FOXM1 inhibitors with in vitro activity against breast cancer cells
Nifuroxazide ameliorates pulmonary fibrosis by blocking myofibroblast genesis: a drug repurposing study
Drug repurposing
Data-driven host-directed antiviral drug repurposing against emerging pathogens
Robust antiviral activity of commonly prescribed antidepressants against emerging coronaviruses: in vitro and in silico drug repurposing studies
Repurposing mesalazine against cardiac fibrosis in vitro
Repurposing of anticancer drugs: in vitro and in vivo activities against Schistosoma mansoni
Radotinib attenuates TGFβ -mediated pulmonary fibrosis in vitro and in vivo: exploring the potential of drug repurposing
Drug repurposing against COVID-19: focus on anticancer agents
Repurposing mebendazole against triple-negative breast cancer CNS metastasis
Repurposing anti-mesothelin CAR-NK immunotherapy against colorectal cancer
Repurposing of approved antivirals against dengue virus serotypes: an in silico and in vitro mechanistic study
A drug repurposing study identifies novel FOXM1 inhibitors with in vitro activity against breast cancer cells
Nifuroxazide ameliorates pulmonary fibrosis by blocking myofibroblast genesis: a drug repurposing study
Drug repurposing
Data-driven host-directed antiviral drug repurposing against emerging pathogens